Litigation Details for IN RE: Palbociclib Patent Litigation (J.P.M.L. 2019)
✉ Email this page to a colleague
IN RE: Palbociclib Patent Litigation (J.P.M.L. 2019)
Docket | ⤷ Try a Trial | Date Filed | 2019-07-17 |
Court | United States Judicial Panel on Multidistrict Litigation | Date Terminated | |
Cause | Assigned To | Colm F. Connolly | |
Jury Demand | Referred To | ||
Patents | 6,936,612; 7,208,489; 7,456,168 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in IN RE: Palbociclib Patent Litigation
Details for IN RE: Palbociclib Patent Litigation (J.P.M.L. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2019-10-02 | 55 | )(B)(iii). 5 U.S. Patent Nos. 6,936,612, 7,208,489, and 7,456,168. … MULTIDISTRICT LITIGATION IN RE: PALBOCICLIB PATENT LITIGATION …, and 125 mg. All the actions are Hatch-Waxman4 patent infringement * Judge Ellen… Under the Drug Price Competition and Patent Term Restoration Act of 1984, Pub. L. No. 98–417… “paragraph IV certification”—stating that the patents listed in the FDA’s Orange Book as covering the | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |